NCT03786627

Brief Summary

Phase I, this study aims to:-

  1. 1.Establish intra- and inter-rater reliability and minimal detectable change of ultrasound imaging measurement
  2. 2.Determine appropriate mode and dose for neuromuscular electrical stimulation on lumbar multifidus muscle
  3. 3.Determine feasibility of proposed protocol and physical therapy intervention
  4. 4.Determine the difference lumbar multifidus muscle activation based on arthrogenic muscle inhibition model between individuals with and without impaired lumbopelvic control
  5. 5.Determine the effect of combined neuromuscular electrical stimulation and motor control training in individual with impaired lumbopelvic control

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

3.8 years

First QC Date

December 20, 2018

Last Update Submit

March 15, 2023

Conditions

Keywords

Clinical lumbar instabilityHistory of low back painArthrogenic muscle inhibitionNeuromuscular electrical stimulationMotor control training

Outcome Measures

Primary Outcomes (9)

  • Muscle thickness of lumbar multifidus muscle at baseline.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle thickness.

    This outcome will be collected at baseline.

  • Muscle thickness of lumbar multifidus muscle after the first intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle thickness.

    This outcome will be collected at immediately after the first intervention.

  • Muscle thickness of lumbar multifidus muscle after 8-week intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle thickness.

    This outcome will be collected at immediately after 8-week intervention.

  • Cross-sectional area of lumbar multifidus muscle at baseline.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle cross-sectional area.

    This outcome will be collected at baseline.

  • Cross-sectional area of lumbar multifidus muscle after the first intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle cross-sectional area.

    This outcome will be collected at immediately after the first intervention.

  • Cross-sectional area of lumbar multifidus muscle after 8-week intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle cross-sectional area.

    This outcome will be collected at immediately after 8-week intervention.

  • Pennation angle of lumbar multifidus muscle at baseline.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle pennation angle.

    This outcome will be collected at baseline.

  • Pennation angle of lumbar multifidus muscle after the first intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle pennation angle.

    This outcome will be collected at immediately after the first intervention.

  • Pennation angle of lumbar multifidus muscle after 8-week intervention.

    The ultrasound imaging device will be used to measure lumbar multifidus muscle pennation angle.

    This outcome will be collected at immediately after 8-week intervention.

Secondary Outcomes (2)

  • Lumbar and hip muscle length.

    This outcome will be collected at baseline only.

  • Abdominal and back muscle strength.

    This outcome will be collected at baseline only.

Study Arms (2)

Combined NMES and motor control

EXPERIMENTAL

This group will receive combined 15-minute neuromuscular electrical stimulation and 30-minute motor control training based on movement system impairment concept.

Other: Combined NMES and motor control

Motor control and placebo NMES

PLACEBO COMPARATOR

This group will receive placebo NMES for 15 minutes followed by 30 minutes motor control training based on movement system impairment concept.

Other: Motor control and placebo NMES

Interventions

This group will receive the neuromuscular electrical stimulation using interferential mode (6000 Hz, beat frequency 20-50 Hz, scanning effect) on bilateral lumbar multifidus muscles. The intensity will be set at the subject's maximum tolerance. Stimulation will be set at 10 seconds on and 60 seconds off to minimize muscle fatigue. The total stimulation time is 15 minutes. After that, this group will receive 30 minutes motor control training. This motor control training will focus on the control of the lumbar multifidus muscle in various functional tasks. It is believed to restore the motor units in individuals with arthrogenic muscle inhibition. This motor control training will take approximately 30 minutes. This group will receive intervention twice a week for 8 weeks.

Combined NMES and motor control

This group will the neuromuscular electrical stimulation without turning the electrical current for 15 minutes. After that, this group will receive 30 minutes motor control training. This motor control training will focus on the control of the lumbar multifidus muscle in various functional tasks. This motor control training will take approximately 30 minutes. This group will receive intervention twice a week for 8 weeks.

Motor control and placebo NMES

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Between the ages of 20 and 40
  • No history of LBP that interferes with activities of daily living and/or required treatment
  • No aberrant movement pattern during active forward bend test
  • Passive straight leg raising test (SLR) less than 91 degrees
  • Between the ages of 20 and 40
  • A recurrent pattern of LBP at least two episodes that interfered with activities of daily living and/or required treatment
  • Presenting aberrant movement pattern during active forward bend test
  • Passive straight leg raising test (SLR) greater than 91 degrees

You may not qualify if:

  • History of seizure for either the subject or any family member
  • Implanted pacemaker
  • Clinical signs of systemic disease
  • Definitive neurologic signs including pain, weakness or numbness in the lower extremity
  • Previous spinal surgery
  • Diagnosed osteoporosis, severe spinal stenosis, and/or inflammatory joint disease
  • Any lower extremity condition that would potentially alter trunk movement
  • Vestibular dysfunction
  • Extreme psychosocial involvement
  • Body mass index (BMI) greater than 30 kg/m2
  • Active treatment of another medical illness that would preclude participation in any aspect of the study
  • Menstruation or pregnancy (for female subject)
  • Diagnosed herniated nucleus pulposus (HNP)
  • Pain medication usage (e.g., NSAID)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Mahidol University

Salaya, Changwat Nakhon Pathom, 73170, Thailand

Location

Related Publications (6)

  • Kiesel KB, Uhl TL, Underwood FB, Rodd DW, Nitz AJ. Measurement of lumbar multifidus muscle contraction with rehabilitative ultrasound imaging. Man Ther. 2007 May;12(2):161-6. doi: 10.1016/j.math.2006.06.011. Epub 2006 Sep 14.

    PMID: 16973400BACKGROUND
  • Teyhen D, Koppenhaver S. Rehabilitative ultrasound imaging. J Physiother. 2011;57(3):196. doi: 10.1016/S1836-9553(11)70044-3.

    PMID: 21843838BACKGROUND
  • Baek SO, Cho HK, Kim SY, Jones R, Cho YW, Ahn SH. Changes in deep lumbar stabilizing muscle thickness by transcutaneous neuromuscular electrical stimulation in patients with low back pain. J Back Musculoskelet Rehabil. 2017;30(1):121-127. doi: 10.3233/BMR-160723.

    PMID: 27341642BACKGROUND
  • Hicks GE, Sions JM, Velasco TO, Manal TJ. Trunk Muscle Training Augmented With Neuromuscular Electrical Stimulation Appears to Improve Function in Older Adults With Chronic Low Back Pain: A Randomized Preliminary Trial. Clin J Pain. 2016 Oct;32(10):898-906. doi: 10.1097/AJP.0000000000000348.

    PMID: 26736024BACKGROUND
  • Sung W PT, PhD, Wong A BS, MS, Pourshogi A PhD, Pourrezaei K PhD, Silfies S PT, PhD. Near infrared spectroscopy confirms recruitment of specific lumbar extensors through neuromuscular electrical stimulation. Physiother Theory Pract. 2020 Apr;36(4):516-523. doi: 10.1080/09593985.2018.1488908. Epub 2018 Jun 28.

    PMID: 29952686BACKGROUND
  • Songjaroen S, Sungnak P, Piriyaprasarth P, Wang HK, Laskin JJ, Wattananon P. Combined neuromuscular electrical stimulation with motor control exercise can improve lumbar multifidus activation in individuals with recurrent low back pain. Sci Rep. 2021 Jul 20;11(1):14815. doi: 10.1038/s41598-021-94402-2.

Study Officials

  • Peemongkon Wattananon, PhD

    Faculty of Physical Therapy, Mahidol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Physical therapist, investigator, and assessor will be blinded to the group assignment. This process will be handled by the research coordinator.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects with impaired lumbopelvic control will be randomly assigned to either combined NMES with motor control training group, or motor control training alone group using randomly generated number in concealed envelopes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 20, 2018

First Posted

December 26, 2018

Study Start

April 1, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 16, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

The IPD of this study will be shared upon official request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The supporting information will be sent upon official request.
Access Criteria
Having an official written request.

Locations